As Democrats Push Single-Payer, Brits Hope To Escape It

Forbes.com | Sally C. Pipes
September 27, 2021

Britain’s National Health Service has long been a source of pride for the country. The organizers of the 2012 London Olympics made the NHS a focus of the Games’ Opening Ceremony. But the country’s publicly funded healthcare system is failing to provide high-quality, accessible care. Its failures should serve as a warning for progressives who want to institute Medicare for All here in the United States.

Read more. . .

We Should Not Lose Sight of the Upcoming Flu Season

Morning Consult | Robert Popovian, Pharm. D., M.S., and Wayne Winegarden, Ph.D.
September 27, 2021

Today, flu immunization rates lag and are far below the Department of Health and Human Services’ Healthy People 2030 goals of 70 percent immunization rate for the entire U.S. population. For example, in 2019-2020, only half of individuals 18 years and older received a flu vaccine, and that was a slight increase compared to the previous year.

Read more. . .

Drug Price Controls Inflict Worse Harm Than Even Critics Recognize

Newsmax | Sally C. Pipes
September 24, 2021

Sure, other countries are free-riding off the research that our drug spending funds. But the United States is much richer, in terms of GDP per capita, than H.R. 3’s reference countries. And the value that innovative drugs deliver to society is far greater than any savings the federal government will realize under the Democrats’ price control scheme.

Read more. . .

High-tech production of organs for transplantation is our future

Big Think | Henry Miller, M.S., M.D.
September 27, 2021

Another medical area that desperately needs breakthroughs is transplantation of solid organs. We are making progress but are not quite there. Currently, donor organs — from a living donor or cadaver — must match the recipient’s tissue type and size, and often, they are not perfect. By one estimate, approximately half of transplanted organs are rejected by recipients’ bodies within 10-12 years, in spite of a constantly expanding understanding of what causes rejection.

Read more. . .